関連する実験動画

Updated: Sep 10, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

患者によって報告されたアウトカムを利用した同位体I相がん臨床試験の設計

Nolan A Wages¹, Ruitao Lin²

¹Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, U.S.A.

Statistics in biopharmaceutical research

|August 22, 2025

まとめ

この研究は,患者によって報告されたアウトカム・アイソトニック (PRO- ISO) 設計という新しい適応設計を導入し,患者によって報告されたアウトカムを使用して,安全に投与量を割り当て,最大許容量 (MTD) を決定します. PRO-ISOの設計は,シミュレーションで既存の方法と比較できる性能を示しています.

科学分野:

臨床試験の設計
薬剤測定法
バイオ統計学

背景:

安全で効果的な薬剤の投与量を決定するには臨床試験の第"段階が不可欠です
従来の方法は患者の経験を完全に捉えることができず,毒性の信号に効果的に適応できないかもしれません.
患者によって報告されたアウトカム (PROs) を統合すると,より患者中心のアプローチが投与量エスカレーションに提供されます.

研究の目的:

患者による結果同位体 (PRO-ISO) 設計という新しい適応的フェーズI臨床試験の設計を導入し,評価する.
患者の報告による結果の継続的な再評価方法 (PRO-CRM) といった確立された方法との間でPRO-ISO設計のパフォーマンスを比較する.
臨床試験における遅発の毒性に対処するために,PRO-ISOの方法論を拡張する.

主な方法:

第I相試験のためのPRO-ISO適応設計の開発
ドーズの配分とターゲットドーズの推奨を含む動作特性を評価するためのシミュレーション試験.
PRO-CRMとの比較と,PROの設定のための非パラメトリック最適基準.
方法論的な拡張は,遅発の毒性を含む.

主要な成果:

PRO-ISOの設計は,患者によって報告された結果の毒性イベントに適応して,効果的に被験者を許容可能な用量に分配します.
シミュレーションの結果は,PRO- ISOが,PRO- CRMと比べて,投与量推薦と患者配分に優れていることを示しています.
PRO-ISOは,PRO設定における非パラメトリック最適基準に比べて高い性能を示しています.

結論:

PRO- ISOの設計は,患者の安全性と投与量の決定を向上させ,フェーズI臨床試験に柔軟かつ効果的なアプローチを提供します.
この新しいデザインは患者の報告した結果を堅牢に統合し薬の耐受性に関する価値ある洞察を提供しています
方法論は,遅発の毒性を含む複雑なシナリオに適応し,臨床適用性を改善します.

キーワード:

投与量を決定するアイソトニック・リグレーション遅発の毒性患者によって報告されたアウトカム

さらに関連する動画

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

関連する概念動画

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...